At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies that advance the existing standard of care, and enrich the lives and treatment alternatives for patients worldwide.
Read more →
Press Release
GAAP to Non-GAAP Recs
Quarterly Summary
Webcast
Transcript